ArticleFrontiers in oncology2020

DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer.

Xianneng Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.